Study shows tofacitinib medication can fix porousness absconds in the digestive tract Kumar Jeetendra | October 6, 2020 A team of researchers led by biomedical scientist Declan F. McCole in the University of California, Riverside, has found that the medication tofacitinib, also called Xeljanz and approved by the FDA to treat rheumatoid arthritis and ulcerative colitis, can fix permeability defects in the intestine. Study results appear in the Journal of Crohn’s and Colitis. …
Study gives conceivable clarification to reformist course of different sclerosis in mice Kumar Jeetendra | October 17, 2020 People with multiple sclerosis (MS) gradually develop increasing functional impairment. Researchers at Karolinska Institutet in Sweden have found a possible explanation for the progressive course of this disease in mice and how it can be reversed. The analysis, which is published in Science Immunology, can prove beneficial to future treatments. MS is a chronic inflammatory …
Study recognizes 17 new genes that could be focused for treatment of psoriasis, dermatitis Kumar Jeetendra | October 27, 2020 A Swedish study has identified 17 new genes which could be targeted for therapy of psoriasis and eczema, two frequent hereditary skin diseases with no cure. Pelin Sahlén, senior lecturer in KTH Royal Institute of Technology, says the joint KTH-Karolinska Institutet research team mapped 118 gene targets regarding the skin ailments, psoriasis and atopic dermatitis, …
Cell scientists and bioimaging master collaborate to settle fourth measurement insider facts Kumar Jeetendra | October 29, 2020 Cell biologists at the University of Illinois in Urbana-Champaign and Bar-Ilan University in Israel and a bioimaging expert at the University of Central Florida are teaming up in what they expect may result in a major breakthrough in the understanding of the three-dimensional organization of the nucleus over their role in certain diseases. The dream …
Blood vessel deformities start in vein cells Kumar Jeetendra | November 3, 2020 In the condition called cavernoma, lesions appear in a cluster of blood vessels in the brain, spinal cord or retina. Researchers from Uppsala University can now reveal, at molecular level, these changes originate in vein cells. This new understanding of the condition creates possibility of developing better treatments for patients. The study was published in …
Researchers use quality treatment to recover harmed optic nerve filaments Kumar Jeetendra | November 5, 2020 Scientists have used gene therapy to regenerate damaged nerve fibers from the eye, in a discovery that could aid the development of new treatments for glaucoma, one of the main causes of blindness worldwide. Axons – nerve pathways – in the adult central nervous system (CNS) do not normally regenerate after injury and disease, meaning …
University of Sheffield and Pfizer dispatch new consortium to quicken improvement of ATMPs Kumar Jeetendra | November 24, 2020 The University of Sheffield and Pfizer have today (23 November 2020) established a new consortium which aims to standardize and accelerate the growth of Advanced Therapy Medicinal Products (ATMPs), allowing potentially transformative remedies to reach patients sooner. The new, five-year consortium, Accelerating Research and Innovation for Advanced Therapies (ARDAT), is supported by the Innovative Medicines …
Study uncovers a quality answerable for anthraquinone synthesis in plants Kumar Jeetendra | November 25, 2020 Anthraquinones are a class of naturally occurring chemicals prized for their medicinal properties, as well as for other programs, including ecologically friendly dyes. Despite broad interest, the mechanism by which plants produce them has remained shrouded in mystery until today. New work from an international group of scientists including Carnegie’s Sue Rhee shows a gene …
FUJIFILM Irvine Scientific dispatches Sterile Express Media Service Kumar Jeetendra | December 4, 2020 FUJIFILM Irvine Scientific, Inc., today announced the launch of Sterile Express Media Service (SEMS), for small, rapid creation of non-GMP media tested for sterility. With SEMS, clients can request up to 100L of media, to be quickly manufactured in a Grade A/ISO 5 sterile environment, and have it shipped within 15 business days pending sterility …
Free radicals might be significant for the brain to stay versatile Kumar Jeetendra | December 6, 2020 Reactive oxygen molecules, also known as”free radicals”, are generally considered dangerous. Researchers from the German Center for Neurodegenerative Diseases (DZNE) and the Center for Regenerative Therapies Dresden (CRTD) at TU Dresden published the findings in the journal Cell Stem Cell. The researchers focused on the”hippocampus”, a brain region that is regarded as the control center …
CRISPR-based test could give fast, affordable testing to help control COVID-19 spread Kumar Jeetendra | December 7, 2020 Imagine swabbing your nostrils, putting the swab in a device, and obtaining a read-out on your mobile phone in 15 to 30 minutes which tells you if you’re infected with the COVID-19 virus. This has been the vision for a group of scientists at Gladstone Institutes, University of California, Berkeley (UC Berkeley), and University of …
Researchers give knowledge on how lung microorganisms secure against attacking microbes Kumar Jeetendra | December 9, 2020 New insight on how bacteria in the lungs protect against invading pathogens has been published today in the open-access eLife journal. The study in mice shows that a strain of lung bacteria called Lactobacillus provides a barrier against Streptococcus pneumoniae (S. pneumoniae) colonisation in animals previously infected with influenza A virus when applied therapeutically following …
